Open AccessReal-world disease activity and sociodemographic, clinical and treatment characteristics of moderate-to-severe inflammatory bowel disease in Brazil
Author(s) -
Cyrla Zaltman,
Rogério Serafim Parra,
Lígia Yukie Sassaki,
Genoile Oliveira Santana,
Maria de Lourdes Abreu Ferrari,
Sender Jankiel Miszputen,
Heda Maria Barska dos Santos Amarante,
Roberto Luiz Kaiser,
Cristina Flores,
Wilson Roberto Catapani,
José Miguel Luz Parente,
Mauro Boiocchi,
Odery Ramos,
Carolina D Gonçalves,
Isabella Miranda Guimaraes,
José Joaquim Ribeiro da Rocha,
Marley Ribeiro Feitosa,
Omar Féres,
Rogério Saad-Hossne,
Francisco Guilherme Cancela e Penna,
Pedro Ferrari Sales Cunha,
Tárcia N. Gomes,
Rodrigo Bremer s,
Mikaell Alexandre Gouvêa Faria,
Mírian Perpétua Palha Dias Parente,
Antônio Scafuto Scotton,
Rosana Fusaro Caratin,
Juliana Senra,
Júlio Maria Fonseca Chebli
Publication year - 2021
Publication title -
world journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.427
H-Index - 155
eISSN - 2219-2840
pISSN - 1007-9327
DOI - 10.3748/wjg.v27.i2.208
Subject(s) - medicine , inflammatory bowel disease , ulcerative colitis , incidence (geometry) , colonoscopy , disease , crohn's disease , faecal calprotectin , calprotectin , colorectal cancer , physics , cancer , optics
Understanding the treatment landscape of inflammatory bowel diseases (IBD) is essential for improving disease management and patient outcomes. Brazil is the largest Latin American country, and it presents socioeconomic and health care differences across its geographical regions. This country has the highest increase in IBD incidence and prevalence in Latin America, but information about the clinical and treatment characteristics of IBD is scarce.